YOUR BUSINESS AUTHORITY
Springfield, MO
Eli Lilly has agreed to buy gene-editing startup Verve Therapeutics.
The deal is valued at up to $1.3 billion.
The agreement calls for an upfront payment of $1 billion, and $300 million will be paid out based on the completion of certain clinical milestones.
Read more from CNBC.
Complete with a 45-foot pedestrian bridge, this project adds a 10-foot-wide walking trail in front of Nixa’s High Pointe Elementary School and Summit Intermediate School.